PTC THERAPEUTICS, INC. - COM (PTCT)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
78.8M
Holdings value Q3 2024
$2.93B
Value change Q3 2024
-$38.9M
Grand Portfolio weight change Q3 2024
0%
Number of holders
199
Number of buys Q3 2024
96
Number of sells Q3 2024
-95
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 78.8M $2.93B -$38.9M $37.10 200
2024 Q2 79.8M $2.44B -$156M $30.58 197
2024 Q1 85.1M $2.47B +$22.3M $29.09 179
2023 Q4 84.6M $2.33B +$98.7M $27.56 172
2023 Q3 81.1M $1.82B -$70.7M $22.41 177
2023 Q2 81M $3.29B +$98.1M $40.67 202
2023 Q1 78.4M $3.8B +$90.7M $48.44 200
2022 Q4 76.8M $2.93B +$11.6M $38.17 196
2022 Q3 76.1M $3.82B +$84.5M $50.20 200
2022 Q2 74M $2.97B +$15.9M $40.06 172
2022 Q1 73.7M $2.75B -$34.4M $37.31 169
2021 Q4 75.1M $2.99B +$33.2M $39.83 166
2021 Q3 74.2M $2.76B +$31.3M $37.21 173
2021 Q2 73.8M $3.12B +$3.82M $42.27 176
2021 Q1 73.2M $3.46B +$45.8M $47.35 196
2020 Q4 72.8M $4.44B +$101M $61.03 205
2020 Q3 71M $3.32B +$114M $46.75 191
2020 Q2 68.3M $3.45B +$258M $50.74 200
2020 Q1 64.2M $2.86B +$127M $44.61 197
2019 Q4 61M $2.93B +$23.6M $48.03 203
2019 Q3 61.8M $2.09B +$115M $33.82 184
2019 Q2 58.3M $2.62B +$30.2M $45.00 174
2019 Q1 58.6M $2.21B +$374M $37.64 174
2018 Q4 48.8M $1.67B +$32.7M $34.32 164
2018 Q3 46.8M $2.2B +$196M $47.00 179
2018 Q2 42.9M $1.45B +$14.4M $33.73 166
2018 Q1 42.7M $1.15B +$143M $27.06 148
2017 Q4 38.1M $635M +$18.9M $16.68 121
2017 Q3 35.7M $715M +$44.6M $20.01 126
2017 Q2 33.5M $614M +$64.1M $18.33 110
2017 Q1 31.5M $310M +$57.1M $9.84 112
2016 Q4 28.7M $313M -$24.5M $10.91 116
2016 Q3 29.2M $409M +$31.6M $14.01 110
2016 Q2 28.6M $202M -$3.64M $7.02 114
2016 Q1 28.8M $186M -$209M $6.44 111
2015 Q4 36.3M $1.18B +$115M $32.40 141
2015 Q3 32.7M $873M -$30.3M $26.70 154
2015 Q2 32.3M $1.55B +$36.9M $48.13 151
2015 Q1 31.4M $1.91B +$209M $60.85 159
2014 Q4 28.4M $1.47B +$199M $51.77 132
2014 Q3 24.4M $1.07B +$72.7M $44.01 99
2014 Q2 22.9M $599M -$830K $26.14 82
2014 Q1 23M $600M +$217M $26.14 64